Cargando…
Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation
PURPOSE: The safety and efficacy of a minimally interrupted novel oral anticoagulant (NOAC) strategy at the time of atrial fibrillation (AF) ablation is uncertain. The purpose of this study was to compare rates of bleeding and thromboembolic events between minimally interrupted NOAC and uninterrupte...
Autores principales: | De Heide, John, Vroegh, Christiaan J., Bhagwandien, Rohit E., Wijchers, Sip A., Szili-Torok, Tamas, Zijlstra, Felix, Lenzen, Mattie J., Yap, S. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292967/ https://www.ncbi.nlm.nih.gov/pubmed/30074120 http://dx.doi.org/10.1007/s10840-018-0417-0 |
Ejemplares similares
-
Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study)()
por: de Heide, John, et al.
Publicado: (2022) -
Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018) -
Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists
por: de Heide, John, et al.
Publicado: (2022) -
Left‐sided phrenic nerve injury during redo pulmonary vein isolation long after a previous contralateral self‐limiting phrenic nerve palsy
por: Kis, Zsuzsanna, et al.
Publicado: (2019) -
Functional electrographic flow patterns in patients with persistent atrial fibrillation predict outcome of catheter ablation
por: Szili‐Torok, Tamas, et al.
Publicado: (2021)